WEBINARS/EVENTS

• The Role Of PUPSIT In A Contamination Control Strategy

  Here, we discuss the relationship between the CCS and PUPSIT, highlight the role of sterilizing grade filtration in the control strategy, and talk about how this can change throughout the product life cycle.

• How To Choose The Best Filtration Device For Your Application

  Learn how to choose the best filtration device for your specific application and understand pore size, membrane material, well volumes and tip types.

• A Scalable, Suspension-Based Viral Vector Manufacturing Platform

  Learn how we helped viral vector CDMO Exothera simplify and streamline their manufacturing process by adding a large-scale suspension-based manufacturing platform, from upstream through downstream processing of viral vectors of up to 2000 L..

• Moving The Needle: A Final Filling Case Study Webinar

  Watch this webinar to hear about a collaboration that helped optimize their new filling line with single-use needles and reduced downtime.

• Getting Ready For SUT X-Ray Irradiation

  In this webinar we compare gamma and X-ray irradiation and explain what testing has been completed and key milestones for readiness for industry.

• How To Scale Up The Production Of Therapeutic Viral Vectors For Gene Therapy Applications

  Learn how you can develop reproducible and scalable processes for viral vector manufacturing in order to meet clinical and commercial market demand in very short timelines.

• Pathways To Success: Expert Insights On Single-Use Technology

  Explore collaboration between biomanufacturers and suppliers, and how partnerships can speed up single-use process implementation and reduce risk.

• How Filter Plates Can Streamline Your Workflow

  In this webinar you will learn how to choose the best filter plate for your specific applications and understand pore size, membrane material, well volumes and tip types.

• Biotech Integrated Solutions From Process Engineering Project Management Experts

  Scaling gene therapy, mAb, or vaccine therapeutic drug products from bench to manufacturing involves a balancing act between project management, risk mitigation, and process parameter selection. In this webinar we explore the ways to apply best practices through implementation of the Biotech Integrated Solutions service architecture for large-scale manufacturing projects, ultimately accelerating speed to market.

• Gene Therapy Downstream Manufacturing, Scale-up And Best Practices

  Join our panel webinar and meet the authors of the recently published gene therapy Ebook: ‘Insights on Successful Gene Therapy Manufacturing and Commercialization’ downstream article.  Hear directly from the authors on various topics related to gene therapy manufacturing and commercialization, the current state of the industry and how we can continue to advance these life-changing medicines.

• Gene Therapy Upstream Manufacturing, Scale-up And Best Practices

  Gene therapies provide innovative options for treating patients, particularly where other traditional therapeutics have been ineffective. The industry continues to grow and mature from research to approved therapeutics. In this panel webinar series, hear directly from the authors of the eBook  "Insights on Successful Gene Therapy Manufacturing and Commercialization" on various topics related to gene therapy manufacturing and commercialization, the current state of the industry and how we can continue to advance these life-changing medicines.

• Implementing Single-Use Technologies In Formulation And Filling Of Vaccines

  Formulation and filling is a critical part of any drug manufacturing process and demands the highest levels of quality and reliability. Pall has a range of technologies and services that enables end users to carry out their operations with increased reliability and flexibility – while ensuring the product quality is designed into the manufacturing process. Using technology from the Allegro™ single-use portfolio, Pall sterilizing grade filters and Pall’s automated solutions ensure that manual interventions are minimized and increased sterility assurance is achieved.

• Developing Scalable Upstream Workflows For Recombinant And Viral Vaccine Processes

  Vaccine manufacturing is responding to challenges for increasing safety assurance and responsiveness in order to reduce the impact of pandemic such as SARS-CoV-2. Therefore, in-depth knowledge of microorganism pathogenicity leads to develop new type of vaccines such as recombinant and viral vaccines. In this presentation we will review the current main upstream vaccine production processes, considering the choice of expression system, the means by which the biological preparation is introduced into the production cell and how Pall’s flexible single-use bioreactors support rapid process development, scale-up and safeguard the quality of life-protecting vaccines and help assure compliance with cGMP.

• Knowledge Transfer, Training Collaboration For Suppliers & Manufacturers

  Watch to learn how a SUT supplier and a biomanufacturer can successfully work together to create an effective training program for GMP-compliant, aseptic, single-use bioprocesses.